Fingerprint
Dive into the research topics of 'Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Gregory G. Schwartz, Michael Szarek, Vera A. Bittner, Rafael Diaz, Shaun G. Goodman, J. Wouter Jukema, Ulf Landmesser, Patricio López-Jaramillo, Garen Manvelian, Robert Pordy, Michel Scemama, Peter Sinnaeve, Harvey D. White, Ph Gabriel Steg, ODYSSEY OUTCOMES Committees and Investigators, Philip E. Aylward, Sam J. Lehman
Research output: Contribution to journal › Article › peer-review
83
Citations
(Scopus)
100
Downloads
(Pure)